Form 4 for EW Edwards Lifesciences
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-08 · accession 0001225208-21-013067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-08 | 2021-10-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $110.49 | -11.1K | 67.3K | -14% | -$1.22M |
| D | 2021-10-08 | 2021-10-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| D | 2021-10-08 | 2021-10-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -11.1K | 66.3K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-08 | S | D | 10,950 | $110.48 | 56,399.40 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $109.9850 to $110.9800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-10-08 | M | A | 11,050 | $21.76 | 67,449.40 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-08 | S | D | 100 | $111.06 | 67,349.40 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2021-10-08 | M | D | 11,050 | $0.00 | 66,300 | D | $21.76 · 2016-05-14 to 2022-05-13 | 11,050 Common Stock |